Cost-cutting generics and biosimilars stuck in legal limbo July 21, 2021 Auto Bot BioPharma, biopharma nl, Legal, News, Policy 0 Many believe that the biosimilar industry can address the issue of spiraling drug costs, but first it has to make it through a thicket of challenges.